Year To Quarter End Statement Of Income

Chordia Therapeutics,Inc - Filing #7267458

Concept 2024-09-01 to
2025-02-28
2023-09-01 to
2024-02-29
Year to quarter end statement of income
Statement of income
Selling, general and administrative expenses
Remuneration for directors (and other officers)
22,900,000 JPY
22,500,000 JPY
Depreciation
361,000 JPY
462,000 JPY
Operating profit (loss)
-996,358,000 JPY
-809,656,000 JPY
Non-operating income
Non-operating income
23,907,000 JPY
11,444,000 JPY
Non-operating expenses
Non-operating expenses
2,680,000 JPY
3,189,000 JPY
Ordinary profit (loss)
-975,131,000 JPY
-801,401,000 JPY
Profit (loss) before income taxes
-975,131,000 JPY
-801,401,000 JPY
Income taxes - current
1,210,000 JPY
1,210,000 JPY
Income taxes
1,210,000 JPY
1,210,000 JPY
Profit (loss)
-976,341,000 JPY
-802,611,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.